CROSS COUNTRY HEALTHCARE INC (CCRN) Fundamental Analysis & Valuation
NASDAQ:CCRN • US2274831047
Current stock price
9.96 USD
-0.24 (-2.35%)
At close:
9.96 USD
0 (0%)
After Hours:
This CCRN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CCRN Profitability Analysis
1.1 Basic Checks
- In the past year CCRN was profitable.
- In the past year CCRN had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
- Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of -21.13%, CCRN is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
- CCRN has a Return On Equity of -29.38%. This is in the lower half of the industry: CCRN underperforms 68.00% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 0.54%, CCRN is doing worse than 63.00% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for CCRN is below the industry average of 8.51%.
- The 3 year average ROIC (6.06%) for CCRN is well above the current ROIC(0.54%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.13% | ||
| ROE | -29.38% | ||
| ROIC | 0.54% |
ROA(3y)-4.3%
ROA(5y)5%
ROE(3y)-5.84%
ROE(5y)13.62%
ROIC(3y)6.06%
ROIC(5y)14.51%
1.3 Margins
- With a Operating Margin value of 0.24%, CCRN is not doing good in the industry: 63.00% of the companies in the same industry are doing better.
- CCRN's Operating Margin has declined in the last couple of years.
- CCRN has a Gross Margin of 20.26%. This is comparable to the rest of the industry: CCRN outperforms 47.00% of its industry peers.
- In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.24% | ||
| PM (TTM) | N/A | ||
| GM | 20.26% |
OM growth 3Y-71.15%
OM growth 5Y-31.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-3.52%
2. CCRN Health Analysis
2.1 Basic Checks
- CCRN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- CCRN has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
- CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 4.89 indicates that CCRN is not in any danger for bankruptcy at the moment.
- The Altman-Z score of CCRN (4.89) is better than 87.00% of its industry peers.
- There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.89 |
ROIC/WACC0.06
WACC8.94%
2.3 Liquidity
- A Current Ratio of 3.78 indicates that CCRN has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 3.78, CCRN belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
- CCRN has a Quick Ratio of 3.78. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of CCRN (3.78) is better than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.78 | ||
| Quick Ratio | 3.78 |
3. CCRN Growth Analysis
3.1 Past
- CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -95.56%.
- The earnings per share for CCRN have been decreasing by -46.59% on average. This is quite bad
- Looking at the last year, CCRN shows a very negative growth in Revenue. The Revenue has decreased by -21.56% in the last year.
- Measured over the past years, CCRN shows a small growth in Revenue. The Revenue has been growing by 4.74% on average per year.
EPS 1Y (TTM)-95.56%
EPS 3Y-84.39%
EPS 5Y-46.59%
EPS Q2Q%-250%
Revenue 1Y (TTM)-21.56%
Revenue growth 3Y-27.85%
Revenue growth 5Y4.74%
Sales Q2Q%-23.61%
3.2 Future
- CCRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 175.50% yearly.
- Based on estimates for the next years, CCRN will show a small growth in Revenue. The Revenue will grow by 0.18% on average per year.
EPS Next Y455.34%
EPS Next 2Y271.84%
EPS Next 3Y175.5%
EPS Next 5YN/A
Revenue Next Year-8.87%
Revenue Next 2Y-2.17%
Revenue Next 3Y0.18%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. CCRN Valuation Analysis
4.1 Price/Earnings Ratio
- CCRN is valuated quite expensively with a Price/Earnings ratio of 498.00.
- Based on the Price/Earnings ratio, CCRN is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
- CCRN is valuated expensively when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
- CCRN is valuated quite expensively with a Price/Forward Earnings ratio of 89.67.
- Based on the Price/Forward Earnings ratio, CCRN is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
- CCRN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.62.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 498 | ||
| Fwd PE | 89.67 |
4.2 Price Multiples
- 69.00% of the companies in the same industry are more expensive than CCRN, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCRN indicates a rather cheap valuation: CCRN is cheaper than 86.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8 | ||
| EV/EBITDA | 11.36 |
4.3 Compensation for Growth
- CCRN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as CCRN's earnings are expected to grow with 175.50% in the coming years.
PEG (NY)1.09
PEG (5Y)N/A
EPS Next 2Y271.84%
EPS Next 3Y175.5%
5. CCRN Dividend Analysis
5.1 Amount
- No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CCRN Fundamentals: All Metrics, Ratios and Statistics
9.96
-0.24 (-2.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04 2026-03-04/amc
Earnings (Next)05-05 2026-05-05/amc
Inst Owners83.99%
Inst Owner Change-0.12%
Ins Owners7.09%
Ins Owner Change17.24%
Market Cap320.71M
Revenue(TTM)1.05B
Net Income(TTM)-94.85M
Analysts74.67
Price Target11.9 (19.48%)
Short Float %4.28%
Short Ratio2.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-157.94%
Min EPS beat(2)-296.08%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-107.17%
Min EPS beat(4)-296.08%
Max EPS beat(4)5.59%
EPS beat(8)3
Avg EPS beat(8)-61.22%
EPS beat(12)6
Avg EPS beat(12)-39.22%
EPS beat(16)10
Avg EPS beat(16)-25.76%
Revenue beat(2)0
Avg Revenue beat(2)-9.09%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-8.72%
Revenue beat(4)0
Avg Revenue beat(4)-7.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-5.84%
Revenue beat(8)0
Avg Revenue beat(8)-4.22%
Revenue beat(12)2
Avg Revenue beat(12)-2.78%
Revenue beat(16)5
Avg Revenue beat(16)-1.59%
PT rev (1m)2.55%
PT rev (3m)1.87%
EPS NQ rev (1m)-4.59%
EPS NQ rev (3m)-388.87%
EPS NY rev (1m)13.77%
EPS NY rev (3m)-7.98%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-7.76%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-3.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 498 | ||
| Fwd PE | 89.67 | ||
| P/S | 0.3 | ||
| P/FCF | 8 | ||
| P/OCF | 6.65 | ||
| P/B | 0.99 | ||
| P/tB | 1.39 | ||
| EV/EBITDA | 11.36 |
EPS(TTM)0.02
EY0.2%
EPS(NY)0.11
Fwd EY1.12%
FCF(TTM)1.25
FCFY12.5%
OCF(TTM)1.5
OCFY15.04%
SpS32.74
BVpS10.03
TBVpS7.19
PEG (NY)1.09
PEG (5Y)N/A
Graham Number2.12403 (-78.67%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.13% | ||
| ROE | -29.38% | ||
| ROCE | 0.68% | ||
| ROIC | 0.54% | ||
| ROICexc | 0.76% | ||
| ROICexgc | 1.17% | ||
| OM | 0.24% | ||
| PM (TTM) | N/A | ||
| GM | 20.26% | ||
| FCFM | 3.8% |
ROA(3y)-4.3%
ROA(5y)5%
ROE(3y)-5.84%
ROE(5y)13.62%
ROIC(3y)6.06%
ROIC(5y)14.51%
ROICexc(3y)6.35%
ROICexc(5y)14.73%
ROICexgc(3y)10.08%
ROICexgc(5y)21.91%
ROCE(3y)7.68%
ROCE(5y)18.37%
ROICexgc growth 3Y-70.95%
ROICexgc growth 5Y-31.89%
ROICexc growth 3Y-71.51%
ROICexc growth 5Y-28.12%
OM growth 3Y-71.15%
OM growth 5Y-31.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-3.52%
F-Score6
Asset Turnover2.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 48.59% | ||
| Cap/Sales | 0.77% | ||
| Interest Coverage | 1.82 | ||
| Cash Conversion | 249.59% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.78 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 4.89 |
F-Score6
WACC8.94%
ROIC/WACC0.06
Cap/Depr(3y)57.55%
Cap/Depr(5y)63.04%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95.56%
EPS 3Y-84.39%
EPS 5Y-46.59%
EPS Q2Q%-250%
EPS Next Y455.34%
EPS Next 2Y271.84%
EPS Next 3Y175.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.56%
Revenue growth 3Y-27.85%
Revenue growth 5Y4.74%
Sales Q2Q%-23.61%
Revenue Next Year-8.87%
Revenue Next 2Y-2.17%
Revenue Next 3Y0.18%
Revenue Next 5YN/A
EBIT growth 1Y103.69%
EBIT growth 3Y-79.18%
EBIT growth 5Y-28.09%
EBIT Next Year307.2%
EBIT Next 3Y80.75%
EBIT Next 5YN/A
FCF growth 1Y-64.01%
FCF growth 3Y-31.6%
FCF growth 5Y12.15%
OCF growth 1Y-59.83%
OCF growth 3Y-28.87%
OCF growth 5Y12.15%
CROSS COUNTRY HEALTHCARE INC / CCRN Fundamental Analysis FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 4 / 10 to CCRN.
What is the valuation status for CCRN stock?
ChartMill assigns a valuation rating of 4 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Fairly Valued.
What is the profitability of CCRN stock?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 2 / 10.
What is the valuation of CROSS COUNTRY HEALTHCARE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for CROSS COUNTRY HEALTHCARE INC (CCRN) is 498 and the Price/Book (PB) ratio is 0.99.
Can you provide the financial health for CCRN stock?
The financial health rating of CROSS COUNTRY HEALTHCARE INC (CCRN) is 9 / 10.